Locations:
Search IconSearch

Cancer

CT scan of female patient bladder cancer
November 26, 2024/Urology & Nephrology/Urology

Use of Interim Imaging To Preserve Eligibility for Vaginal-Sparing Cystectomy

Retrospective study evaluates clinical upstaging during neoadjuvant treatment

Microscopic view of bladder cancer with variant histology
November 19, 2024/Urology & Nephrology/Urology

Nonmuscle Invasive Bladder Cancer With Variant Histology: When To Consider a Bladder-Sparing Approach

Retrospective study finds acceptable cancer control among most histologic subtypes with intravesical therapy

Incision after surgery to remove sarcoma
November 13, 2024/Orthopaedics/Tumor

Up to 94% Accuracy at Predicting Wound Complications After Sarcoma Resection

Machine learning models assess intraoperative tissue perfusion

Interactive culinary medicine class
November 11, 2024/Cancer/Innovations

Integrative Oncology Improves Outcomes and Quality of Life

Combining mind, body and lifestyle practices in alignment with conventional cancer treatment

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Pregnant woman
November 6, 2024/Cancer/News & Insight

Large Retrospective Study Finds Pregnancy Safe Among Young BRCA Carriers

Pregnancy did not appear to increase the risk of recurrence in patients or complications in their children

Young patient with cancer
October 25, 2024/Cancer/News & Insight

Multidisciplinary Care Model Supports Young People with Cancer

Integrated program addresses growing need for comprehensive cancer care among adolescents, young adults and adults under 50 with early onset cancers

Hurthle cell carcinoma
October 24, 2024/Cancer/News & Insight

Researchers Uncover Clues to Treating Rare Thyroid Cancer

Studies find mTOR inhibitor may play key role in treating Hurthle cell carcinoma

Eye with a lesion on the iris

Iris Freckle, Mole or Melanoma? How to Tell the Difference

A new online calculator can determine probability of melanoma

DNA
October 10, 2024/Cancer/Research

Blocking YES1 Protein Resensitizes Triple-Negative Breast Cancer to Treatment

Obstructing key protein allows for increased treatment uptake for taxane chemotherapy

BackPage 1 of 137Next

Advertisement

Ad